PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Cancer's Disruptive Dozen

AZ Seizes the Mobile Moment

Brexit and UK Pharma

Regulatory
Major Changes Proposed for Medicare Drug Coverage
Rapid growth in Medicare spending on prescription drugs is prompting a leading advisory group to recommend significant revisions in how the government pays for medicines under Part D and Part B.
... /Read more/
Advertisement
Integrated Payer-Provide Networks are motivated to influence MD behavior. Read this article to learn what you need to know about how to influence IPPNs.
Regulatory
Support Grows for Wider Use of Real World Evidence
FDA is working with sponsors to use real world evidence (RWE) to confirm results from initial clinical trials, particularly when product approval is based on limited studies. Jill Wechsler reports.
... /Read more/
Advertisement
Tufts CSDD Study Offers New Model to Maximise Sponsor-CRO Partnerships
Learn how to foster a shared vision that enables you to effectively harness multidisciplinary expertise across partnerships with Tufts CSDD's integrated, patient-centric approach to creating impactful operational strategies.
Learn more
Q&A
Research Data Promise Vs. Reality
Michael Christel speaks to Ken Getz of the Tufts Center for the Study of Drug Development, who outlines how the convergence of health data and technology will be key to lasting gains for clinical research
... /Read more/
Advertisement
Considering changing product access vendors? Watch this brief video to learn an effective 4-point methodology to optimize your program transition by addressing data conversion, implementation planning, stakeholder communications, and technology.
Learn more
Special Feature
Pharm Exec's Top 50 Companies
Pharm Exec's 16th annual listing of the top biopharma players may look placid on the surface, but, upon deeper inspection, does point to important transitions taking place in the larger business model.
... /Read more/
Advertisement
Breaking the Circle of Distrust with a Radical PLC Pricing Model
LIVE WEBCAST: Thursday, June 30, 2016 at 10 am EDT | 3 pm BST | 4 pm CEST
Free registration
Calendar
/ August 15–17: 10th Annual Forum on Transparency and Aggregate Spend /
Washington, DC.
/ September 15–16: Compliance Congress for Specialty Products /
Boston, MA
/ October 27–28: MedComm 2016 /
San Francisco, CA
/ December 13–14: Life Sciences Trade and Channel Strategies /
Philadelphia, PA
/ February 22–23, 2017: Speaker Programs 2017 /
Philadelphia, PA
Advertisement
Best Practices for Integrating Biomarkers across the Drug Development Continuum
On Demand
Learn more
 
 
Advertisement
Considering Biosimilars: A Panel Discussion Exploring Perceptions and Potential Adoption
On Demand
Learn more
Industry update
//Aprea AB (Stockholm, Sweden and Boston, MA) named Christian S. Schade as President and Chief Executive Officer.//MedAvante, Inc. (Hamilton, NJ) announced two new members of its Board of Directors: Richard F. Cimino, former Covance EVP and Group President of Clinical Development and Commercialization Services, and Nigel Brown, former Corporate Vice President of Business Development and Strategy at Covance.//Adherium Limited (Melbourne, Australia) announced the establishment of Adherium North America, Inc., based in San Francisco, CA, and appointed James Hattersley as Senior Vice President of Business Development, North America.//
Advertisement
Strategic considerations for clinical development programs in emerging biopharma companies
On Demand
Learn more
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com